Adaptive Biotechnologies Corporation (ADPT) vs GeneDx Holdings Corp. (WGS)
Adaptive Biotechnologies Corporation and GeneDx Holdings Corp. are both Diagnostics & Research companies. Adaptive Biotechnologies Corporation is the larger, with a market value of $4.7B against $2.6B — 1.8× the size. Adaptive Biotechnologies Corporation grew revenue faster over the last twelve months: 50.1% against 25.4%. Adaptive Biotechnologies Corporation has the higher net margin (−20.7% vs −23.4%) and the higher return on invested capital (−16.6% vs −27.7%). Across the 18 metrics below, Adaptive Biotechnologies Corporation leads on 13 and GeneDx Holdings Corp. on 5.
Valuation
Profitability
| Metric | ADPT | WGS | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 75.57% | 69.37% | 50.89% |
| Operating margin | (12.16%) | (20.34%) | (8.57%) |
| Net margin | (20.73%) | (23.40%) | (6.37%) |
| Free cash flow margin | (7.80%) | (16.68%) | 0.00% |
| Return on equity | (38.68%) | (40.80%) | (2.92%) |
| Return on assets | (11.23%) | (22.50%) | (6.71%) |
| Return on invested capital | (16.57%) | (27.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack